The induced anti-PD-L1 antibodies can kill PD-L1-expressing tumor cells through multiple mechanisms, including inhibition of PD-L1 interaction with PD-1 on CTLs, antibody-dependent cellular cytotoxicity (ADCC), and complement-dependent cytotoxicity (CDC) (13, 37, 42). This evidence concerns the gene CD274 and neoplasm.